123 related articles for article (PubMed ID: 15838346)
1. Renal protective effect of YM598, a selective endothelin type A receptor antagonist.
Sugimoto K; Fujimori A; Yuyama H; Tahara A; Fujimura A
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S451-4. PubMed ID: 15838346
[TBL] [Abstract][Full Text] [Related]
2. Renal protective effect of YM598, a selective endothelin ET(A) receptor antagonist, against diabetic nephropathy in OLETF rats.
Sugimoto K; Tsuruoka S; Fujimura A
Eur J Pharmacol; 2002 Aug; 450(2):183-9. PubMed ID: 12206857
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of YM598, a selective endothelin-A receptor antagonist.
Sudoh K; Yuyama H; Noguchi Y; Fujimori A; Ukai M; Ohtake A; Sato S; Sasamata M; Miyata K
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S390-3. PubMed ID: 15838329
[TBL] [Abstract][Full Text] [Related]
4. Effect of eplerenone, enalapril and their combination treatment on diabetic nephropathy in type II diabetic rats.
Kang YS; Ko GJ; Lee MH; Song HK; Han SY; Han KH; Kim HK; Han JY; Cha DR
Nephrol Dial Transplant; 2009 Jan; 24(1):73-84. PubMed ID: 18682491
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of YM598, an orally active and highly potent selective endothelin ET(A) receptor antagonist.
Yuyama H; Sanagi M; Koakutsu A; Mori M; Fujimori A; Harada H; Sudoh K; Miyata K
Eur J Pharmacol; 2003 Sep; 478(1):61-71. PubMed ID: 14555186
[TBL] [Abstract][Full Text] [Related]
6. Effect of YM218, a nonpeptide vasopressin V(1A) receptor-selective antagonist, on rat mesangial cell hyperplasia and hypertrophy.
Tahara A; Tsukada J; Tomura Y; Suzuki T; Yatsu T; Shibasaki M
Vascul Pharmacol; 2007 Jun; 46(6):463-9. PubMed ID: 17395547
[TBL] [Abstract][Full Text] [Related]
7. Superiority of YM598 over atrasentan as a selective endothelin ETA receptor antagonist.
Yuyama H; Noguchi Y; Fujimori A; Ukai M; Fujiyasu N; Ohtake A; Sato S; Sudoh K; Sasamata M; Miyata K
Eur J Pharmacol; 2004 Sep; 498(1-3):171-7. PubMed ID: 15363992
[TBL] [Abstract][Full Text] [Related]
8. Hyperlipidaemia and the progression of nephropathy in OLETF rats: effect of angiotensin-converting enzyme inhibitor, enalapril.
Sugimoto K; Tsuruoka S; Fujimura A
Clin Exp Pharmacol Physiol; 1999 Aug; 26(8):601-7. PubMed ID: 10474773
[TBL] [Abstract][Full Text] [Related]
9. Effect of enalapril on diabetic nephropathy in OLETF rats: the role of an anti-oxidative action in its protective properties.
Sugimoto K; Tsuruoka S; Fujimura A
Clin Exp Pharmacol Physiol; 2001 Oct; 28(10):826-30. PubMed ID: 11553023
[TBL] [Abstract][Full Text] [Related]
10. YM598, an orally active ET(A) receptor antagonist, ameliorates the progression of cardiopulmonary changes and both-side heart failure in rats with cor pulmonale and myocardial infarction.
Fujimori A; Miyauchi T; Sakai S; Yuyama H; Iemitsu M; Sanagi M; Sudoh K; Goto K; Shikama H; Yamaguchi I
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S354-7. PubMed ID: 15838319
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of a selective endothelin-A receptor antagonist YM598 on endothelin-1-induced potentiation of nociception in formalin-induced and prostate cancer-induced pain models in mice.
Yuyama H; Koakutsu A; Fujiyasu N; Fujimori A; Sato S; Shibasaki K; Tanaka S; Sudoh K; Sasamata M; Miyata K
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S479-82. PubMed ID: 15838353
[TBL] [Abstract][Full Text] [Related]
12. Effect of YM598, a selective endothelin ETA receptor antagonist, on endothelin-1-induced bone formation.
Someya A; Yuyama H; Fujimori A; Ukai M; Fukushima S; Sasamata M
Eur J Pharmacol; 2006 Aug; 543(1-3):14-20. PubMed ID: 16843458
[TBL] [Abstract][Full Text] [Related]
13. Strict angiotensin blockade prevents the augmentation of intrarenal angiotensin II and podocyte abnormalities in type 2 diabetic rats with microalbuminuria.
Nishiyama A; Nakagawa T; Kobori H; Nagai Y; Okada N; Konishi Y; Morikawa T; Okumura M; Meda I; Kiyomoto H; Hosomi N; Mori T; Ito S; Imanishi M
J Hypertens; 2008 Sep; 26(9):1849-59. PubMed ID: 18698221
[TBL] [Abstract][Full Text] [Related]
14. Possible role of VEGF in the progression of kidney disease in streptozotocin (STZ)-induced diabetic rats: effects of an ACE inhibitor and an angiotensin II receptor antagonist.
Kakizawa H; Itoh Y; Imamura S; Matsumoto T; Ishiwata Y; Ono Y; Yamamoto K; Kato T; Hayakawa N; Oda N; Goto Y; Goto Y; Nagasaka A; Senda T; Itoh M
Horm Metab Res; 2004 Jul; 36(7):458-64. PubMed ID: 15305228
[TBL] [Abstract][Full Text] [Related]
15. Chronic administration of an endothelin-A receptor antagonist improves exercise capacity in rats with myocardial infarction-induced congestive heart failure.
Miyauchi T; Fujimori A; Maeda S; Iemitsu M; Sakai S; Shikama H; Tanabe T; Matsuda M; Goto K; Yamaguchi I
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S64-7. PubMed ID: 15838361
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo effects of endothelin-1 and YM598, a selective endothelin ET A receptor antagonist, on the lower urinary tract.
Ukai M; Yuyama H; Fujimori A; Koakutsu A; Sanagi M; Ohtake A; Sato S; Sudoh K; Sasamata M; Miyata K
Eur J Pharmacol; 2008 Feb; 580(3):394-400. PubMed ID: 18078923
[TBL] [Abstract][Full Text] [Related]
17. Effect of single oral administration of YM598, a novel selective endothelin ETA receptor antagonist, on blood pressure in normotensive and hypertensive rats.
Yuyama H; Sonoda R; Shibasaki K; Fujimori A; Sudoh K; Sasamata M; Miyata K
Vascul Pharmacol; 2004 Feb; 41(1):27-34. PubMed ID: 15135329
[TBL] [Abstract][Full Text] [Related]
18. Pitavastatin ameliorates albuminuria and renal mesangial expansion by downregulating NOX4 in db/db mice.
Fujii M; Inoguchi T; Maeda Y; Sasaki S; Sawada F; Saito R; Kobayashi K; Sumimoto H; Takayanagi R
Kidney Int; 2007 Aug; 72(4):473-80. PubMed ID: 17568784
[TBL] [Abstract][Full Text] [Related]
19. A novel and selective endothelin ET(A) receptor antagonist YM598 prevents the development of chronic hypoxia-induced pulmonary hypertension in rats.
Yuyama H; Fujimori A; Sanagi M; Koakutsu A; Noguchi Y; Sudoh K; Sasamata M; Miyata K
Vascul Pharmacol; 2005 Jun; 43(1):40-6. PubMed ID: 15975532
[TBL] [Abstract][Full Text] [Related]
20. Changes of endothelin in streptozotocin-induced diabetic rats: effects of an angiotensin converting enzyme inhibitor, enalapril maleate.
Itoh Y; Imamura S; Yamamoto K; Ono Y; Nagata M; Kobayashi T; Kato T; Tomita M; Nakai A; Itoh M; Nagasaka A
J Endocrinol; 2002 Oct; 175(1):233-9. PubMed ID: 12379508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
